Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cognyte Software Ltd. - Ordinary Shares (NQ: CGNT )

9.660 -0.120 (-1.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cognyte Software Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
COGNYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Cognyte Software Ltd. on Behalf of Cognyte Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Business Wire
COGNYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Cognyte Software Ltd. on Behalf of Cognyte Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cognyte Software Ltd. (CGNT) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cognyte Software Ltd. (CGNT) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Cognyte Software Ltd. (CGNT) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into Cognyte Software Ltd. (CGNT)
NEW YORK, NY / ACCESSWIRE / June 3, 2022 / Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international shareholder and consumer rights litigation firm, is investigating whether Cognyte Software... 
From Scott+Scott Attorneys at Law LLP
Via AccessWire
Topics Economy
Exposures Supply Chain
Cognyte Expands its Strategic Partner Program to Drive Business Growth
From Cognyte
Via Business Wire
Analyst Ratings For Cognyte Software
Over the past 3 months, 4 analysts have published their opinion on Cognyte Software (NASDAQ:CGNT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Mid-Afternoon Market Update: Dow Falls 150 Points; Cognyte Software Shares Drop
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 150 points on Tuesday. 
Via Benzinga
Mid-Day Market Update: Dow Dips Over 100 Points; Sunshine Biopharma Shares Surge
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; ISM Services PMI Rises To 58.3 In March
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 150 points on Tuesday. 
Via Benzinga
Cognyte Announces Fourth Quarter and Fiscal Year Ended January 31, 2022 Results
From Cognyte Software Ltd.
Via Business Wire
Earnings Scheduled For April 5, 2022
Companies Reporting Before The Bell • Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $2.37 per share on revenue of $884.62 million. 
Via Benzinga
Cognyte to Announce Fourth Quarter and FY2022 Full-Year Financial Results on April 5, 2022
From Cognyte Software Ltd.
Via Business Wire
Where Cognyte Software Stands With Analysts
Cognyte Software (NASDAQ:CGNT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Cognyte to Participate in the 24th Annual Needham Virtual Growth Conference
From Cognyte Software Ltd.
Via Business Wire
75 Biggest Movers From Yesterday
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE: 
Via Benzinga
46 Stocks Moving In Monday's Mid-Day Session
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) climbed 369% to $7.32 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Barclays lifted the price target on FactSet Research Systems Inc. (NYSE: 
Via Benzinga
Cognyte Announces Third Quarter Results
From Cognyte Software Ltd.
Via Business Wire
Earnings Scheduled For December 21, 2021
Companies Reporting Before The Bell • Imperial Petroleum (NASDAQ:IMPP) is expected to report earnings for its third quarter. • General Mills (NYSE:GIS) is... 
Via Benzinga
Frost & Sullivan’s 2021 Digital Intelligence Solutions Report Names Cognyte a Leader in the Global Digital Intelligence Market
From Cognyte Software
Via Business Wire
Cognyte to Announce Third Quarter Financial Results on December 21, 2021
From Cognyte Software Ltd.
Via Business Wire
Cognyte Wins “Milipol Innovation Award 2021”
From Cognyte Software Ltd.
Via Business Wire
Cognyte Software Shares Drop On Weak Q3 Outlook
Security analytics software firm Cognyte Software Ltd (NASDAQ: CGNT) reported second-quarter revenue growth of 9.5% year-on-year on a non-GAAP basis to $116.... 
Via Benzinga
Cognyte Announces Second Quarter Results
From Cognyte Software Ltd.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.